Antivenin (crotalidae) polyvalent Pregnancy and Breastfeeding Warnings
Brand names: Anavip, Antivenin Polyvalent, CroFab
Medically reviewed by Drugs.com. Last updated on Oct 4, 2023.
Antivenin (crotalidae) polyvalent Pregnancy Warnings
Use is not recommended unless clearly needed.
US FDA pregnancy category: C
Comments:
-This product contains ethyl mercury from thimerosal.
-Limited data on high dose and acute exposures to methyl mercury associate it with neurological and renal toxicities.
-Developing fetuses and very young children are more susceptible to methyl mercury toxicity.
Animal studies have not been conducted. There are no controlled data in human pregnancy.
US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
Antivenin (crotalidae) polyvalent Breastfeeding Warnings
Caution is recommended.
Excreted into human milk: Unknown
Excreted into animal milk: Data not available
See also
References for pregnancy information
- "Product Information. CroFab (antivenin (Crotalidae) polyvalent)." Savage Laboratories
References for breastfeeding information
- "Product Information. CroFab (antivenin (Crotalidae) polyvalent)." Savage Laboratories
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
